Autonomous Vehicles and Public Health.


Journal

Annual review of public health
ISSN: 1545-2093
Titre abrégé: Annu Rev Public Health
Pays: United States
ID NLM: 8006431

Informations de publication

Date de publication:
02 04 2020
Historique:
pubmed: 1 2 2020
medline: 20 4 2021
entrez: 1 2 2020
Statut: ppublish

Résumé

Autonomous vehicles (AVs) have the potential to shape urban life and significantly modify travel behaviors. "Autonomous technology" means technology that can drive a vehicle without active physical control or monitoring by a human operator. The first AV fleets are already in service in US cities. AVs offer a variety of automation, vehicle ownership, and vehicle use options. AVs could increase some health risks (such as air pollution, noise, and sedentarism); however, if proper regulated, AVs will likely reduce morbidity and mortality from motor vehicle crashes and may help reshape cities to promote healthy urban environments. Healthy models of AV use include fully electric vehicles in a system of ridesharing and ridesplitting. Public health will benefit if proper policies and regulatory frameworks are implemented before the complete introduction of AVs into the market.

Identifiants

pubmed: 32004116
doi: 10.1146/annurev-publhealth-040119-094035
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

329-345

Auteurs

David Rojas-Rueda (D)

Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins, Colorado 80523, USA; email: david.rojas@colostate.edu.
ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona 08003, Spain; email: mark.nieuwenhuijsen@isglobal.org.

Mark J Nieuwenhuijsen (MJ)

ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona 08003, Spain; email: mark.nieuwenhuijsen@isglobal.org.
Universitat Pompeu Fabra (UPF), Barcelona 08003, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid 28029, Spain.
Municipal Institute of Medical Research (IMIM), Hospital del Mar, Barcelona 08003, Spain.

Haneen Khreis (H)

ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona 08003, Spain; email: mark.nieuwenhuijsen@isglobal.org.
Universitat Pompeu Fabra (UPF), Barcelona 08003, Spain.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid 28029, Spain.
Center for Advancing Research in Transportation Emissions, Energy, and Health (CARTEEH), Texas A&M Transportation Institute (TTI), Texas 77843, USA; email: H-Khreis@tti.tamu.edu.

Howard Frumkin (H)

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, Washington 98195, USA; email: frumkin@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH